1. High Levels of Cyclooxygenase-2 Expression are Associated with Prostate Cancer. (November 2017) Authors: Olaniyi, P.O.; Whiteland, H.; Coker, C.; Kynaston, H.; Doak, S. Journal: International journal of surgery Issue: Volume 47(2017)Supplement 1 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prostate Cancer Progression: Aspirin Causes Cell Cycle Quiescence in Prostate Cancer Cells. (July 2018) Authors: Oluseyi Olalekan Olaniyi, P.; Whiteland, H.; Shah, U.K.; Bodger, O.; Verma, J.; Coker, C.; Kynaston, H.; Doak, S. Journal: International journal of surgery Issue: Volume 55(2018)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prostate Cancer Progression: Aspirin Induces Toxicity in Prostate Cancer Cell. (November 2017) Authors: Olaniyi, P.O.; Whiteland, H.; Shah, U.K.; Bodger, O.; Verma, J.; Haboubi, H.; Rees, B.; Kynaston, H.; Doak, S. Journal: International journal of surgery Issue: Volume 47(2017)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prostate cancer progression: Sodium salicylate, the active metabolite of aspirin inhibits nuclear factor-kappa B (NFκB) pathway. (July 2018) Authors: Oluseyi Olalekan Olaniyi, P; Whiteland, H.; Shah, U.K.; Bodger, O.; Haboubi, H.; Kynaston, H.; Doak, S. Journal: International journal of surgery Issue: Volume 55(2018)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗